146 related articles for article (PubMed ID: 29987323)
1. Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine.
Le P; Rothberg MB
JAMA Intern Med; 2018 Sep; 178(9):1277-1278. PubMed ID: 29987323
[TBL] [Abstract][Full Text] [Related]
2. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
Dooling KL; Guo A; Patel M; Lee GM; Moore K; Belongia EA; Harpaz R
MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(3):103-108. PubMed ID: 29370152
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
Le P; Rothberg MB
Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live.
Curran D; Patterson BJ; Van Oorschot D; Buck PO; Carrico J; Hicks KA; Lee B; Yawn BP
Hum Vaccin Immunother; 2019; 15(4):765-771. PubMed ID: 30625011
[TBL] [Abstract][Full Text] [Related]
5. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
Brotherton AL; Shah R
R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
[TBL] [Abstract][Full Text] [Related]
6. Update on recommendations for use of herpes zoster vaccine.
Hales CM; Harpaz R; Ortega-Sanchez I; Bialek SR;
MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(33):729-31. PubMed ID: 25144544
[TBL] [Abstract][Full Text] [Related]
7. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
Anderson TC; Masters NB; Guo A; Shepersky L; Leidner AJ; Lee GM; Kotton CN; Dooling KL
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):80-84. PubMed ID: 35051134
[TBL] [Abstract][Full Text] [Related]
8. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
Weaver BA;
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
[TBL] [Abstract][Full Text] [Related]
9. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
You JHS; Ming WK; Lee CF; Tsang OT; Chan PK
Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
[TBL] [Abstract][Full Text] [Related]
11. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
James SF; Chahine EB; Sucher AJ; Hanna C
Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.
Le P; Rothberg MB
JAMA Intern Med; 2018 Feb; 178(2):248-258. PubMed ID: 29297049
[TBL] [Abstract][Full Text] [Related]
13. Limited Focus in Evaluation of Vaccine Cost-effectiveness.
Curran D; Van Oorschot D; Buck P
JAMA Intern Med; 2018 Nov; 178(11):1563-1564. PubMed ID: 30398554
[No Abstract] [Full Text] [Related]
14. Limited Focus in Evaluation of Vaccine Cost-effectiveness-Reply.
Le P; Rothberg MB
JAMA Intern Med; 2018 Nov; 178(11):1564. PubMed ID: 30398559
[No Abstract] [Full Text] [Related]
15. Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis.
Le P; Rothberg MB
J Gen Intern Med; 2017 Feb; 32(2):159-167. PubMed ID: 27743284
[TBL] [Abstract][Full Text] [Related]
16. Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
Le P; Rothberg MB
Am J Prev Med; 2017 Dec; 53(6):829-836. PubMed ID: 29153126
[TBL] [Abstract][Full Text] [Related]
17. Which patients should receive the herpes zoster vaccine?
Short MD; Fergus C
JAAPA; 2019 Sep; 32(9):18-20. PubMed ID: 31460969
[TBL] [Abstract][Full Text] [Related]
18. Update on vaccine-preventable diseases: are adults in your community adequately protected?
Schaffner W
J Fam Pract; 2008 Apr; 57(4 Suppl):S1-11; quiz S12. PubMed ID: 18655764
[TBL] [Abstract][Full Text] [Related]
19. Update From the Advisory Committee on Immunization Practices.
O'Leary ST; Maldonado YA; Byington CL
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):215-218. PubMed ID: 28903515
[TBL] [Abstract][Full Text] [Related]
20. What are the new vaccination recommendations for herpes zoster?
Mospan CM; Colvin N
JAAPA; 2018 Oct; 31(10):14-15. PubMed ID: 30252758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
